ArticleContemporary clinical trials communications2026
Effect of vitamin D supplementation on sexual function in women with type 2 diabetes: Study protocol for a randomized, double-blind, placebo controlled clinical trial.
Article in Contemporary clinical trials communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Female sexual dysfunction (FSD) is a common and often overlooked complication of type 2 diabetes, adversely affecting quality of life and marital satisfaction. It involves vascular, neurological, hormonal, and psychological mechanisms. Vitamin D deficiency, prevalent among individuals with type 2 diabetes, is associated with metabolic disturbances, endothelial dysfunction, and may contribute to impaired sexual function. Although some studies in healthy women with low vitamin D levels suggest benefit, evidence on its effect in women with type 2 diabetes is limited. Methods: This randomized, double-blind, placebo-controlled clinical trial investigates whether weekly vitamin D supplementation improves sexual function in reproductive-age women with type 2 diabetes. One hundred eligible participants will be randomly allocated (1:1) to receive either vitamin D (50,000 IU) or placebo weekly for 12 weeks. The primary outcome is change in total Female Sexual Function Index (FSFI) score from baseline to week 13. Secondary analyses will explore relationships with glycemic control (HbA1c and fasting blood sugar), body mass index (BMI), and demographic factors. Women with severe stress, anxiety, or depression, as assessed by the Depression, Anxiety and Stress Scale (DASS-21), will be excluded. Compliance will be monitored via weekly follow-up, and analyses will follow the intention-to-treat principle using appropriate statistical tests at a significance level of 0.05. Discussion: This trial will provide evidence on the effectiveness of vitamin D supplementation in improving sexual function among women with type 2 diabetes, potentially offering a safe and cost-effective approach to enhance metabolic and sexual health. Trial registration: Iranian Registry of Clinical Trials, IRCT20150624022896N3 (registered 2024-02-27).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.